MAC Clinical Research - Cannock

Cannock WS11 0BN

0 studies enrolling now · 3 studies all time

What they study most

Irritable Bowel Syndrome, Psoriasis

Studies at this site

• Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis — Running, not enrolling
• An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis — Completed
• A Trial for New Treatment of Adult Participants With Irritable Bowel Syndrome — Completed